Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delivering antibacterials to the lungs: considerations for optimizing outcomes.

Mario Cazzola1, Francesco Blasi, Claudio Terzano

  • 1Department of Respiratory Medicine, Unit of Pneumology and Allergology, A Cardarelli Hospital, Naples, Italy. mcazzola@qubisoft.it

American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions
|January 15, 2004
PubMed
Summary

Achieving sustained antibacterial concentrations in the lung is crucial for treating lower respiratory tract infections. Serum concentrations may be a better predictor of bacterial clearance than lung tissue concentrations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe asthma: One disease and multiple definitions.

The World Allergy Organization journal·2021
Same author

The Isoform GC1f of the Vitamin D Binding Protein Is Associated with Bronchiectasis Severity.

Biomedicines·2021
Same author

Manifesto on the Value of Adult Immunization: "We Know, We Intend, We Advocate".

Vaccines·2021
Same author

ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments.

The World Allergy Organization journal·2021
Same author

A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement.

Respiratory medicine·2021
Same author

MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy.

Journal of developmental biology·2021

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Lung infection sterilization depends on sustained antibacterial drug levels.
  • Measuring antimicrobial concentrations in various lung tissues (bronchial mucosa, epithelial lining fluid, alveolar macrophages) is of growing interest.
  • Different antibiotic classes exhibit varying penetration and concentration levels within lung compartments.

Purpose of the Study:

  • To explore the significance of pulmonary pharmacokinetics and pharmacodynamics in treating lower respiratory tract infections.
  • To evaluate the correlation between drug concentrations at infection sites and therapeutic outcomes.
  • To compare the predictive value of lung tissue versus serum drug concentrations for bacterial clearance.

Main Methods:

Related Experiment Videos

  • Review of existing literature on antimicrobial concentrations in lung tissues and fluids.
  • Analysis of pharmacokinetic data in the context of drug penetration into bronchial mucosa, epithelial lining fluid, and alveolar macrophages.
  • Examination of the pharmacodynamic approach integrating drug disposition and minimum inhibitory concentration (MIC) values.

    • Main Results:

    • Fluoroquinolones and macrolides achieve higher lung concentrations than penicillins and cephalosporins.
    • Antibacterials penetrate bronchial mucosa well, but concentrations may not reach blood levels.
    • While lung concentrations are important, some studies indicate serum concentrations correlate better with pulmonary bacterial clearance.

    Conclusions:

    • Pulmonary pharmacokinetics is essential for understanding drug behavior in the lung.
    • The pharmacodynamic approach, linking drug concentration to microbiological effect, is critical for anti-infective therapy.
    • Serum drug concentrations might be a more reliable indicator of treatment efficacy in lower respiratory tract infections than lung tissue concentrations.